Last reviewed · How we verify
PROTOCOL FOR THE TREATMENT Acute Lymphoblastic Leukemia With Ph 'NEGATIVE IN ELDERLY PATIENTS (> 55 Years)
The protocol objective is providing adequate treatment and based on broad consensus in elderly patients with Acute Lymphoblastic Leukemia (ALL). Apply uniform treatment that enables a joint analysis of results strong enough to make conclusions on specific subgroups of patients (genotypic subtypes, particularly LAL Bcr/abl positive, phenotype, or strata of age or associated diseases). Provide results of a treatment to consider standard against which to compare the results of phase II trials of experimental drugs that undoubtedly will be activated in the coming years
Details
| Lead sponsor | PETHEMA Foundation |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 100 |
| Start date | 2007-06-30 |
| Completion | 2022-12 |
Conditions
- Acute Lymphoblastic Leukemia
Interventions
- Dexamethasona, Idarubicine, ARA-C, Methotrexate
Primary outcomes
- Efficacy in terms of response rate — 5 years
Countries
Spain